

![]() |
Long-term ganciclovir therapy for hepatitis B virus infection after liver transplantation |
|
Authors | ![]() | |
Published in | Journal of hepatology. 1999, vol. 31, no. 4, p. 584-92 | |
Abstract | Hepatitis B virus (HBV) disease on a liver graft is associated with florid viral replication and graft failure. The aim of this study performed between 1992 and 1995 was to investigate the safety and efficacy of long-term intravenous ganciclovir for HBV infection in liver transplant recipients. | |
Keywords | Adult — Antiviral Agents/adverse effects/therapeutic use — DNA, Viral/analysis — Female — Ganciclovir/adverse effects/therapeutic use — Hepatitis B/drug therapy/immunology/pathology — Hepatitis B Antigens/analysis — Hepatitis B virus/genetics — Humans — Liver/pathology — Liver Transplantation — Male — Middle Aged — Postoperative Complications/drug therapy — Prospective Studies — Time Factors — Treatment Outcome | |
Identifiers | PMID: 10551379 | |
Full text | ||
Structures | ||
Research group | Hépatologie chirurgicale (327) | |
Citation (ISO format) | ROCHE, B et al. Long-term ganciclovir therapy for hepatitis B virus infection after liver transplantation. In: Journal of Hepatology, 1999, vol. 31, n° 4, p. 584-92. doi: 10.1016/S0168-8278(99)80335-3 https://archive-ouverte.unige.ch/unige:73132 |